The White House confirmed on Sunday that President Joe Biden has been diagnosed with metastatic prostate cancer, a stage in which the disease has spread beyond the prostate gland and is regarded as serious.
Former White House physician Ronny Jackson, who served Presidents Barack Obama and Donald Trump, said he had consulted several urologists after the announcement and that they all agreed the cancer is far advanced. He estimated that the president’s remaining lifespan could be between twelve and eighteen months, although he expressed hope that the timeline might be longer.
Jackson suggested that the president may have been aware of his prostate condition before it was made public and that this information might not have been disclosed to the electorate. He noted that he performed annual medical examinations for both Obama and Trump, including prostate‑specific antigen testing, and explained that prostate cancer can often be treated on an outpatient basis, allowing procedures to be completed in a few hours without hospital admission.
The former doctor placed responsibility on Dr Kevin O’Connor, Biden’s longtime physician, asserting that O’Connor either provided false information or was incompetent. O’Connor had previously reported that the president was being treated for benign prostatic hyperplasia before the 2020 election.
Additional details emerged that the president had made a casual reference to having cancer in a speech delivered in 2022, and that a bruise appeared on his left hand in the days preceding his departure from office.
Context and implications
Prostate cancer is among the most common cancers affecting men in the United States, with more than two hundred thousand new cases diagnosed each year. When the disease becomes metastatic, treatment options typically include surgery, radiation therapy, hormone therapy, chemotherapy and active surveillance, often administered on an outpatient basis.
The disclosure raises questions about how the White House manages and discloses health information, particularly in light of the Health Insurance Portability and Accountability Act, which obliges health providers to keep patients’ medical information confidential, even for public officials. The episode may prompt renewed discussion about the duties of the White House physician in balancing privacy with the public’s right to know.
Health officials stress the importance of prostate cancer awareness and regular screening, urging readers in the United States and Canada to discuss appropriate testing with their doctors.